FDA Reveals Rare, Possibly Fatal Neurological Disorder Is A “Potential Risk” With New Pfizer Vaccine

People around the globe have suffered serious adverse reactions resulting from COVID vaccines, especially from the Pfizer shot.

Now the Food and Drug Administration (FDA) tells us another Pfizer vaccine can cause serious complications in recipients. After receiving Pfizer’s Respiratory Syncytial Virus (RSV) shot during a clinical trial, two older individuals contracted Guillain-Barré syndrome.

This was enough for the FDA to flag the disease as “an important potential risk” from the RSV shot. Yet Pfizer is still seeking approval for general public use.

According to the Mayo Clinic, Guillain-Barré syndrome is a rare disorder in which your body’s immune system attacks your nerves.

While most people recover from Guillain-Barre syndrome, some severe cases can be fatal. Other serious cases can result in paralysis.

There’s no known cure for Guillain-Barre syndrome.

Keep reading